Dr. Saha obtained his DVM then M.S. degree, both in Veterinary Medicine from Bangladesh Agriculture University, and Ph.D. degree in Veterinary Medicine (Virology) from Ghent University, Belgium. He received his post-doctoral training in Cancer Immunology & Oncolytic Immunovirotherapy at the University of Helsinki, Finland and then five years at Harvard Medical School, Massachusetts. Prior to joining California Northstate University College of Pharmacy (CNUCOP), he was an Assistant Professor at Texas Tech University Health Sciences, Abilene. Dr. Saha’s research focuses on the areas of cancer immunology and immunotherapy and application of oncolytic viruses for the treatment of cancers. Currently, he has a DoD-PRCRP active grant titled “Immunotherapeutic targeting of glioblastoma with oncolytic virus and listeria-based anti-cancer vaccine”. Dr. Saha is now expanding his research in understanding the pathobiology of pulmonary arterial hypertension (PAH) and recapitulating pathological features of various vascular disorders using organ-on-a-chip technology.